CO5261555A1 - Linezolid-forma cristalina ii - Google Patents

Linezolid-forma cristalina ii

Info

Publication number
CO5261555A1
CO5261555A1 CO01005901A CO01005901A CO5261555A1 CO 5261555 A1 CO5261555 A1 CO 5261555A1 CO 01005901 A CO01005901 A CO 01005901A CO 01005901 A CO01005901 A CO 01005901A CO 5261555 A1 CO5261555 A1 CO 5261555A1
Authority
CO
Colombia
Prior art keywords
linezolid
crystal form
oxazolidinyl
mfi
jpeg
Prior art date
Application number
CO01005901A
Other languages
English (en)
Spanish (es)
Inventor
Michael David Bergren
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22658183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5261555(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CO5261555A1 publication Critical patent/CO5261555A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO01005901A 2000-02-02 2001-01-26 Linezolid-forma cristalina ii CO5261555A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17983700P 2000-02-02 2000-02-02

Publications (1)

Publication Number Publication Date
CO5261555A1 true CO5261555A1 (es) 2003-03-31

Family

ID=22658183

Family Applications (1)

Application Number Title Priority Date Filing Date
CO01005901A CO5261555A1 (es) 2000-02-02 2001-01-26 Linezolid-forma cristalina ii

Country Status (30)

Country Link
EP (1) EP1255754B1 (https=)
JP (1) JP5235256B2 (https=)
KR (3) KR100864745B1 (https=)
CN (1) CN1221547C (https=)
AR (1) AR027261A1 (https=)
AT (1) ATE297920T1 (https=)
AU (1) AU782138B2 (https=)
BR (1) BR0107667A (https=)
CA (1) CA2395603C (https=)
CO (1) CO5261555A1 (https=)
CZ (1) CZ302292B6 (https=)
DE (1) DE60111497T2 (https=)
DK (1) DK1255754T3 (https=)
EA (1) EA004434B1 (https=)
EE (1) EE05197B1 (https=)
ES (1) ES2242728T3 (https=)
HU (1) HUP0301076A3 (https=)
IL (1) IL151010A0 (https=)
MX (1) MXPA02007471A (https=)
MY (1) MY122829A (https=)
NO (2) NO323459B1 (https=)
NZ (1) NZ520541A (https=)
PE (1) PE20011086A1 (https=)
PL (1) PL356433A1 (https=)
PT (1) PT1255754E (https=)
SI (1) SI1255754T1 (https=)
SK (1) SK287025B6 (https=)
TW (1) TWI297687B (https=)
WO (1) WO2001057035A1 (https=)
ZA (1) ZA200205162B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
PT1673370E (pt) 2003-10-16 2009-11-05 Symed Labs Ltd Forma cristalina de linezolida
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
CA2572207A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd. Solid forms of linezolid and processes for preparation thereof
US20060142283A1 (en) * 2004-06-29 2006-06-29 Judith Aronhime Crystalline form IV of linezolid
WO2006091731A2 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
MX2007002113A (es) * 2005-06-22 2007-04-27 Teva Pharma Formas polimorfas de maleato de tegaserod.
AU2006277017A1 (en) * 2005-07-20 2007-02-15 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical composition comprising linezolid form IV
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
EP2099299A4 (en) * 2006-10-23 2011-11-30 Concert Pharmaceuticals Inc OXAZOLIDINONE DERIVATIVES AND METHOD FOR THEIR USE
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
MX2012012627A (es) 2010-04-30 2013-05-09 Univ Indiana Res & Tech Corp Proceso para preparar linezolid.
EP2603505A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
EP2603506A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
WO2012114354A1 (en) * 2011-02-24 2012-08-30 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
EP2683696A1 (en) 2011-03-09 2014-01-15 Synthon BV Process for making crystalline form a of linezolid
CN102731341A (zh) * 2011-04-13 2012-10-17 上海医药工业研究院 用于制备利奈唑胺的中间体及其制备方法
CN102766106A (zh) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 利奈唑胺的新晶型及其制备方法
CN102399200B (zh) * 2011-12-14 2013-12-04 浙江新东港药业股份有限公司 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
IN2014DN06213A (https=) 2012-01-24 2015-10-23 Jubilant Life Sciences Ltd
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) * 2012-04-10 2012-08-22 杭州华东医药集团生物工程研究所有限公司 一种利奈唑胺晶型及其制备方法
EP2917189B1 (en) 2012-11-09 2016-08-17 Synthon BV Process for making linezolid
DK3541442T3 (da) 2016-11-16 2022-03-14 Persica Pharmaceuticals Ltd Antibiotiske formuleringer mod lændesmerter
DK3709970T3 (da) * 2017-11-16 2025-07-07 Persica Pharmaceuticals Ltd Linezolidformuleringer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
DK1114819T3 (da) * 1996-04-11 2008-04-14 Pharmacia & Upjohn Co Llc Fremgangsmåde til fremstilling af oxazolidinoner
EP1772453A1 (en) * 1997-11-07 2007-04-11 Pharmacia & Upjohn Company LLC Process to produce Oxazolidinones

Also Published As

Publication number Publication date
PT1255754E (pt) 2005-11-30
KR20080044358A (ko) 2008-05-20
MY122829A (en) 2006-05-31
EP1255754B1 (en) 2005-06-15
AR027261A1 (es) 2003-03-19
CN1394207A (zh) 2003-01-29
JP5235256B2 (ja) 2013-07-10
CZ20022635A3 (cs) 2002-10-16
EA004434B1 (ru) 2004-04-29
SK9942002A3 (en) 2002-11-06
PL356433A1 (en) 2004-06-28
CN1221547C (zh) 2005-10-05
AU3275501A (en) 2001-08-14
EE05197B1 (et) 2009-08-17
NO20065836L (no) 2002-08-01
WO2001057035A1 (en) 2001-08-09
SK287025B6 (sk) 2009-10-07
DE60111497D1 (de) 2005-07-21
HUP0301076A2 (hu) 2003-08-28
HUP0301076A3 (en) 2004-06-28
CZ302292B6 (cs) 2011-02-09
IL151010A0 (en) 2003-02-12
AU782138B2 (en) 2005-07-07
SI1255754T1 (sl) 2005-12-31
KR20070087178A (ko) 2007-08-27
HK1051196A1 (en) 2003-07-25
ATE297920T1 (de) 2005-07-15
NZ520541A (en) 2004-02-27
NO20023654L (no) 2002-08-01
KR20020072300A (ko) 2002-09-14
DK1255754T3 (da) 2005-08-22
JP2003522175A (ja) 2003-07-22
ZA200205162B (en) 2003-09-29
PE20011086A1 (es) 2001-10-04
CA2395603A1 (en) 2001-08-09
NO20023654D0 (no) 2002-08-01
TWI297687B (en) 2008-06-11
EE200200420A (et) 2003-12-15
KR100781815B1 (ko) 2007-12-03
BR0107667A (pt) 2002-10-08
NO323459B1 (no) 2007-05-14
KR100864745B1 (ko) 2008-10-22
CA2395603C (en) 2010-03-23
DE60111497T2 (de) 2006-05-18
EP1255754A1 (en) 2002-11-13
EA200200819A1 (ru) 2003-02-27
MXPA02007471A (es) 2002-12-13
ES2242728T3 (es) 2005-11-16

Similar Documents

Publication Publication Date Title
CO5261555A1 (es) Linezolid-forma cristalina ii
DE60329287D1 (de) Boehmitteilchen und diese enthaltende polymermaterialien
JP2003522175A5 (https=)
DE60141543D1 (de) Spritzenzylinder und Halter
AU1826202A (en) Treatment of gastrointestinal stromal tumors
DE60231749D1 (de) Supercharge-nachrichtenaustauschvorrichtung
NO992226D0 (no) Nye forbindelser for anvendelse som neuro-protektive midler
MY134568A (en) Cb2 receptor agonists
PT1663236E (pt) Combinação compreendendo n-(3-metoxi-5-metilpirazin-2-il)-2-(4- [1,3,4-oxadiazol-2-il]fenil)piridina-3-sulfonamida e um bifosfonato
GEP20074236B (en) Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
IL155122A0 (en) New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
DE60112903D1 (de) Oxazolidinon-thioamide mit piperazinamid-substituenten
TR199800679T2 (xx) Kiral metil fenil oksazolidinon.
NZ332990A (en) oral pharmaceutical composition containing a H+, K+-atpase inhibitor having a extended blood plasma profile
PL359847A1 (pl) Kompozycja w postaci cząstek, zawierająca eletryptan, o kontrolowanym uwalnianiu według profilu sigmoidalnego
SI1545710T1 (sl) Uporaba N-(3-metoksi-5-metilpirazin-2-il)-2-(4-(1,3,4-oksadiazol-2-il)fenil) piridin-3-sulfonamida v zdravljenju raka
EG23929A (en) Isoxazolines derivatives and their use as antidepressants
DE60306982D1 (de) Digital-Analog-Wandler, Verzögerungsregelschleife, Speichergerät und Zählverfahren
DK1229936T3 (da) Anvendelse af anti-idiotypiske antistoffer som vacciner mod cancer
CO5271703A1 (es) Compuestos quimicos
EE200200532A (et) Intravenoosselt manustatava linesoliidi lahuse mahuti
AR028032A1 (es) Aparato para cortar y revolver cuajada
CO5170420A1 (es) Nuevos farmacos hidrocloruro
TR200102984T2 (tr) Madraftalazin trevlerinin ”n iltihaplandìrìcì sitokinlerin engelleyicileri olarak kullanìmì

Legal Events

Date Code Title Description
FC Application refused